missing translation for 'onlineSavingsMsg'
Learn More

ErbB4/Her4 Antibody (182818) [DyLight 755], Novus Biologicals™

Mouse Monoclonal Antibody

Marke:  Novus Biologicals FAB11311Z

Artikelnummer. 18534235

  • 831.00 CHF / 0.10 Milliliter

om dit product te kopen Registreer vandaag om een webaccount aan te maken

Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen

Beschreibung

Beschreibung

ErbB4/Her4 Monoclonal antibody specifically detects ErbB4/Her4 in Human samples. It is validated for Flow Cytometry, CyTOF
TRUSTED_SUSTAINABILITY
Spezifikation

Spezifikation

ErbB4/Her4
Monoclonal
DyLight 755
50mM Sodium Borate
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Human
Purified
Flow Cytometry, CyTOF
182818
Flow Cytometry, CyTOF-ready
avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4, EC 2.7.10, EC 2.7.10.1, HER4MGC138404, p180erbB4, Proto-oncogene-like protein c-ErbB-4, receptor tyrosine-protein kinase erbB-4, Tyrosine kinase-type cell surface receptor HER4, v-erb-a avian erythroblastic leukemia viral oncogene homolog-like 4, v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)
Mouse myeloma cell line NS0-derived recombinant human ErbB4/Her4, Glu26-Arg649, Accession # Q15303
0.1 mL
Angiogenesis, Cancer, Protein Kinase, Tumor Suppressors
2066
Store at 4°C in the dark.
IgG2a
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.